UPC Key Statistics, Chart & Performance
The current stock price of UPC is 4.31 USD. In the past month the price increased by 1.89%. In the past year, price decreased by -82.89%.
UPC Latest News, Press Relases and Analysis
UPC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.37 | 1.01T | ||
| JNJ | JOHNSON & JOHNSON | 19.69 | 492.44B | ||
| MRK | MERCK & CO. INC. | 12.55 | 274.34B | ||
| PFE | PFIZER INC | 7.96 | 144.87B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.52 | 113.72B | ||
| ZTS | ZOETIS INC | 20.06 | 56.04B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.77 | 23.19B | ||
| VTRS | VIATRIS INC | 5.48 | 14.70B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.45 | 11.66B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.54B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.53B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 5.05B |
Related stock screener links
About UPC
Company Profile
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
Company Info
UNIVERSE PHARMACEUTICALS INC
265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone
Ji'an JIANGXI CN
Employees: 225
Phone: 867968403309
UNIVERSE PHARMACEUTICALS INC / UPC FAQ
What does UNIVERSE PHARMACEUTICALS INC do?
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
Can you provide the latest stock price for UNIVERSE PHARMACEUTICALS INC?
The current stock price of UPC is 4.31 USD. The price increased by 2.13% in the last trading session.
Does UNIVERSE PHARMACEUTICALS INC pay dividends?
UPC does not pay a dividend.
What is the ChartMill technical and fundamental rating of UPC stock?
UPC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for UNIVERSE PHARMACEUTICALS INC?
UNIVERSE PHARMACEUTICALS INC (UPC) operates in the Health Care sector and the Pharmaceuticals industry.
What is the market capitalization of UPC stock?
UNIVERSE PHARMACEUTICALS INC (UPC) has a market capitalization of 2.41M USD. This makes UPC a Nano Cap stock.
Who owns UNIVERSE PHARMACEUTICALS INC?
You can find the ownership structure of UNIVERSE PHARMACEUTICALS INC (UPC) on the Ownership tab.
UPC Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to UPC. When comparing the yearly performance of all stocks, UPC is a bad performer in the overall market: 96.49% of all stocks are doing better.
UPC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to UPC. UPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
UPC Financial Highlights
Over the last trailing twelve months UPC reported a non-GAAP Earnings per Share(EPS) of 191.57. The EPS increased by 106.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.65% | ||
| ROA | 1.35% | ||
| ROE | 1.97% | ||
| Debt/Equity | 0.04 |